Skip to main content

Amgen Breaks Ground on Biomanufacturing Center

Published 3/25/2022
Amgen - Holly Springs Biomanufacturing Center
Amgen - Holly Springs Biomanufacturing Center

Amgen broke ground in March of 2022 on a $550 million biomanufacturing center in Holly Springs, N.C. Accommodating the company's FleXBatch platform, the project will integrate traditional methods for drug substance production with single-use bioprocessing technologies to create a hybrid facility with unrivaled operational efficiencies. The next-generation plant will manufacture advanced therapeutics for the treatment of cardiovascular disease, cancer, osteoporosis, inflammation, and other conditions. Integrated Project Services is leading the design and construction management team for the 225,000-sf complex, which will include a warehouse and a multi-story laboratory and support building. Production will begin at the site in 2025 with construction continuing through 2029. 

Located in the Friendship Innovation Park, the sustainable development will leverage advanced mechanical systems to deliver significant energy and water savings while substantially reducing carbon emissions and waste disposal. Amgen is committed to achieving carbon neutrality by 2027. 

Organization Project Role
Integrated Project Services
Designer and Construction Manager